Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Medical Oncology (Northwood, London, England)|April 23, 2017
Prognostic impact of PD-1 and its ligands in renal cell carcinomaFranziska Erlmeier, Wilko Weichert, Andres Jan Schrader, et al.Oncology|June 27, 2022
Growth Arrest-Specific 6 in Chromophobe Renal Cell CarcinomaMarie Mikuteit, Stefanie Zschäbitz, Maximilian Erlmeier, et al.BMC Urology|May 11, 2023
Immunohistochemical expression of the hepatocyte growth factor in chromophobe renal cell carcinomaMaximilian Erlmeier, Marie Mikuteit, Stefanie Zschäbitz, et al.Medical Oncology (Northwood, London, England)|March 30, 2017
PD-L2: A prognostic marker in chromophobe renal cell carcinoma?Franziska Erlmeier, Wilko Weichert, Michael Autenrieth, et al.Oncotarget|November 21, 2017
Comparison of isolation platforms for detection of circulating renal cell carcinoma cellsYvonne Maertens, Verena Humberg, Franziska Erlmeier, et al.Journal of Clinical Medicine|May 30, 2019
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell CarcinomaAndreas Kahlmeyer, Christine G Stöhr, Arndt Hartmann, et al.Journal of Cancer Research and Clinical Oncology|December 10, 2016
Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell linesJulia Kneissl, Anja Hartmann, Nicole Pfarr, et al.Virchows Archiv : an International Journal of Pathology|July 4, 2019
Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assaysKristina Schwamborn, Johannes U Ammann, Ruth Knüchel, et al.European Urology Open Science|August 2, 2021
In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on 99mTc-sestamibi Single Photon Emission Computed Tomography/Computed Tomography ExaminationThomas Papathomas, Antonios Tzortzakakis, Na Sun, et al.Cancers|April 12, 2022
MALDI Mass Spectrometry Imaging-Prognostic Pathways and Metabolites for Renal Cell CarcinomasFranziska Erlmeier, Na Sun, Jian Shen, et al.Pageof 4